These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16890937)

  • 1. Changes in mGlu5 receptor expression in the basal ganglia of reserpinised rats.
    Ismayilova N; Verkhratsky A; Dascombe MJ
    Eur J Pharmacol; 2006 Sep; 545(2-3):134-41. PubMed ID: 16890937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity.
    Zhu JW; Yuan JF; Yang HM; Wang ST; Zhang CG; Sun LL; Yang H; Zhang H
    Biochimie; 2012 Mar; 94(3):617-27. PubMed ID: 21964032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
    Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract.
    Messenger MJ; Dawson LG; Duty S
    Neuropharmacology; 2002 Aug; 43(2):261-71. PubMed ID: 12213280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release.
    Homayoun H; Stefani MR; Adams BW; Tamagan GD; Moghaddam B
    Neuropsychopharmacology; 2004 Jul; 29(7):1259-69. PubMed ID: 15010696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
    Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
    Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats.
    Ismayilova N; Crossman A; Verkhratsky A; Brotchie J
    Eur J Pharmacol; 2004 Aug; 497(2):187-95. PubMed ID: 15306204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine).
    Anderson JJ; Bradbury MJ; Giracello DR; Chapman DF; Holtz G; Roppe J; King C; Cosford ND; Varney MA
    Eur J Pharmacol; 2003 Jul; 473(1):35-40. PubMed ID: 12877935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.
    Coccurello R; Breysse N; Amalric M
    Neuropsychopharmacology; 2004 Aug; 29(8):1451-61. PubMed ID: 15039773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease.
    Silverdale MA; McGuire S; McInnes A; Crossman AR; Brotchie JM
    Exp Neurol; 2001 Jun; 169(2):400-6. PubMed ID: 11358453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease.
    Phillips JM; Lam HA; Ackerson LC; Maidment NT
    Eur J Neurosci; 2006 Jan; 23(1):151-60. PubMed ID: 16420425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
    Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
    Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
    Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
    Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson's disease model.
    Bai XX; Gu L; Yang HM; Xi SS; Xia N; Zhang S; Zhang H
    Toxicol Lett; 2018 May; 288():71-81. PubMed ID: 29458170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia.
    Kosinski CM; Risso Bradley S; Conn PJ; Levey AI; Landwehrmeyer GB; Penney JB; Young AB; Standaert DG
    J Comp Neurol; 1999 Dec; 415(2):266-84. PubMed ID: 10545164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors.
    Yu M; Tueckmantel W; Wang X; Zhu A; Kozikowski AP; Brownell AL
    Nucl Med Biol; 2005 Aug; 32(6):631-40. PubMed ID: 16026710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts.
    Yu TS; Wang SD; Liu JC; Yin HS
    Exp Neurol; 2001 Apr; 168(2):231-41. PubMed ID: 11259111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
    Lindemann L; Jaeschke G; Michalon A; Vieira E; Honer M; Spooren W; Porter R; Hartung T; Kolczewski S; Büttelmann B; Flament C; Diener C; Fischer C; Gatti S; Prinssen EP; Parrott N; Hoffmann G; Wettstein JG
    J Pharmacol Exp Ther; 2011 Nov; 339(2):474-86. PubMed ID: 21849627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.